cerrar
Tagged with Clinical Trials

Göran A. Ando – Chairman of the Board, Novo Nordisk…
Dr Göran A. Ando, former chairman of Novo Nordisk and a Swedish life sciences industry veteran, recently moved back to his home country after over 35…

Alzheimer’s Disease R&D Expenditure Snapshot 2019
Alzheimer's drugs represent a high-risk, high-reward proposition for global pharma. As David H. Crean recently wrote for PharmaBoardroom, "Except for…

Ming-Shiang Wu – Director, Taiwan Clinical Trial Consortium
Professor Ming-Shiang Wu, director of the Taiwan Clinical Trial Consortium, elaborates on the activities of the organization and its role to promote…

Sweden Pharma R&D Snapshot
Over EUR 1 billion was spent in Sweden on pharmaceutical R&D in 2015, a similar level to spending seen in Italy and Denmark. Made with…

Taiwan Innovation Snapshot
As part of its 'Asia Silicon Valley Development Plan', Taiwan has designated a special focus to each of its regions. The Taiwanese government is…

dMed: More Than Just a CRO
Amidst the sea of Big Pharma executives jumping ship to start highly regarded and attention-grabbing biotech companies, bolstered by the huge influx…

AI in Clinical Trials: Improving Efficiency, Reducing Costs
Paul Bleicher, CEO at OptumLabs, and one of the speakers at the FT US Pharma & Biotech Summit on May 14, shares insights on the benefits we will…

Basyouni Abuseif – Country President and CPO Head, Novartis…
Basyouni Abuseif, country president and CPO Head at Novartis Egypt, explains how the Swiss company has taken over the leadership position in the…

Bertrand Sohier – VP & General Manager Business and…
Bertrand Sohier, VP and general manager business and administration of Parexel France discusses the latest trends impacting the clinical research…

Aurora Berra – General Manager, Sobi Spain and Portugal
Aurora Berra, general manager of Sobi Spain and Portugal, highlights her key priorities and the opportunities and challenges inherent in the…

Mohamed Swilam – Country Manager, Roche Egypt
Mohamed Swilam, country manager of Roche Egypt, explains how ensuring access to medicine in Egypt is not only related to pricing challenges, but also…

Jin Hyoung Kang – President, Cancer Study Group, South…
Dr Jin Hyoung Kang, president of the Cancer Study Group comments on the scope for oncology drug development in Korea, and the issues resulting from…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here